602 related articles for article (PubMed ID: 27131608)
41. Iontophoresis for the cutaneous delivery of nanoentraped drugs.
Andrade JFM; Cunha-Filho M; Gelfuso GM; Gratieri T
Expert Opin Drug Deliv; 2023 Jun; 20(6):785-798. PubMed ID: 37119173
[TBL] [Abstract][Full Text] [Related]
42. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
43. Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model.
Amoozgar Z; Wang L; Brandstoetter T; Wallis SS; Wilson EM; Goldberg MS
Biomacromolecules; 2014 Nov; 15(11):4187-94. PubMed ID: 25251833
[TBL] [Abstract][Full Text] [Related]
44. Design of triptorelin loaded nanospheres for transdermal iontophoretic administration.
Nicoli S; Santi P; Couvreur P; Couarraze G; Colombo P; Fattal E
Int J Pharm; 2001 Feb; 214(1-2):31-5. PubMed ID: 11282233
[TBL] [Abstract][Full Text] [Related]
45. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
46. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
Wang Y; Zeng L; Song W; Liu J
Drug Deliv Transl Res; 2022 Jan; 12(1):15-26. PubMed ID: 33486687
[TBL] [Abstract][Full Text] [Related]
47. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
Narvekar M; Xue HY; Wong HL
Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
[TBL] [Abstract][Full Text] [Related]
48. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
49. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye.
Gomaa YA; El-Khordagui LK; Garland MJ; Donnelly RF; McInnes F; Meidan VM
J Pharm Pharmacol; 2012 Nov; 64(11):1592-602. PubMed ID: 23058046
[TBL] [Abstract][Full Text] [Related]
50. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
51. Design and Characterization of Apocynin Loaded PLGA Nanoparticles and their In vivo Efficacy in Hyperoxaluric Rats.
Sharma S; Parmar A; Bhardwaj R; Bijarnia RK; Kaur T
Curr Drug Deliv; 2018; 15(7):1020-1027. PubMed ID: 29493454
[TBL] [Abstract][Full Text] [Related]
52. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
[TBL] [Abstract][Full Text] [Related]
53. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
54. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
55. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease.
Kalaria DR; Singhal M; Patravale V; Merino V; Kalia YN
Eur J Pharm Biopharm; 2018 Jun; 127():204-212. PubMed ID: 29477356
[TBL] [Abstract][Full Text] [Related]
56. Cutaneous biodistribution of ionizable, biolabile aciclovir prodrugs after short duration topical iontophoresis: Targeted intraepidermal drug delivery.
Chen Y; Zahui T; Alberti I; Kalia YN
Eur J Pharm Biopharm; 2016 Feb; 99():94-102. PubMed ID: 26592154
[TBL] [Abstract][Full Text] [Related]
57. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
58. A transdermal delivery system to enhance quercetin nanoparticle permeability.
Bennet D; Kim S
J Biomater Sci Polym Ed; 2013; 24(2):185-209. PubMed ID: 23565597
[TBL] [Abstract][Full Text] [Related]
59. Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori.
Lotfipour F; Valizadeh H; Milani M; Bahrami N; Ghotaslou R
Drug Res (Stuttg); 2016 Jan; 66(1):41-5. PubMed ID: 25919643
[TBL] [Abstract][Full Text] [Related]
60. Quantification of nanoparticle uptake into hair follicles in pig ear and human forearm.
Raber AS; Mittal A; Schäfer J; Bakowsky U; Reichrath J; Vogt T; Schaefer UF; Hansen S; Lehr CM
J Control Release; 2014 Apr; 179():25-32. PubMed ID: 24486055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
